| Date | Time | Source | Headline | Symbol | Company |
| 11/12/2007 | 8:00AM | PR Newswire (US) | Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 10/30/2007 | 4:35PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Current report filing (8-K) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 10/30/2007 | 4:35PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Current report filing (8-K) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 10/30/2007 | 4:05PM | PR Newswire (US) | Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 10/25/2007 | 4:32PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Current report filing (8-K) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 10/22/2007 | 4:00PM | PR Newswire (US) | Lexicon to Report Third Quarter 2007 Financial Results on October 30, 2007 | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 10/15/2007 | 4:05PM | PR Newswire (US) | Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 10/04/2007 | 4:00PM | PR Newswire (US) | Lexicon Pharmaceuticals to Present at Bio InvestorForum | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 09/27/2007 | 4:00PM | PR Newswire (US) | Lexicon Pharmaceuticals to Present at ThinkEquity ThinkClinic | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 09/26/2007 | 5:13PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De (Other) (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 09/26/2007 | 4:33PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De (Other) (3) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 09/25/2007 | 4:50PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De (Other) (8-K) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 09/25/2007 | 4:00PM | PR Newswire (US) | Lexicon Appoints Judith Swain, M.D. to Board of Directors | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 09/20/2007 | 9:30AM | PR Newswire (US) | Lexicon Pharmaceuticals to Present at the UBS Global Life Sciences Conference | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 08/23/2007 | 3:18PM | PR Newswire (US) | Lexicon Pharmaceuticals Announces Stockholder Approval of Invus Investment of Up to $550 Million | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 08/21/2007 | 4:00PM | PR Newswire (US) | Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 08/13/2007 | 1:59PM | PR Newswire (US) | Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 07/31/2007 | 4:00PM | PR Newswire (US) | Lexicon Pharmaceuticals Reports 2007 Second Quarter Financial Results | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 07/31/2007 | 6:30AM | PR Newswire (US) | Lexicon Drug Candidate for Cognitive Disorders Successfully Completes Phase 1 Clinical Trial | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 07/19/2007 | 6:30AM | PR Newswire (US) | Lexicon to Report Second Quarter 2007 Financial Results on July 31, 2007 | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 07/02/2007 | 6:00PM | PR Newswire (US) | Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 06/18/2007 | 2:29AM | PR Newswire (US) | /C O R R E C T I O N -- Lexicon Pharmaceuticals, Inc./ | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 06/17/2007 | 7:41PM | PR Newswire (US) | Lexicon Pharmaceuticals Announces Two Agreements to Finance Long-Term Drug Development Strategy | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 06/08/2007 | 7:30AM | PR Newswire (US) | Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune Deficiency | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 06/07/2007 | 7:30AM | PR Newswire (US) | Lexicon Pharmaceuticals to Present at the Needham Biotechnology & Medical Technology Conference | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 05/23/2007 | 7:30AM | PR Newswire (US) | Lexicon Pharmaceuticals to Present at the Bank of America Health Care Conference | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 05/15/2007 | 7:30AM | PR Newswire (US) | Lexicon Pharmaceuticals Named One of the Best Places to Work by The Scientist | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 05/07/2007 | 7:30AM | PR Newswire (US) | Lexicon to Present at the BIO 2007 International Convention | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 05/01/2007 | 7:30AM | PR Newswire (US) | Lexicon Pharmaceuticals Reports 2007 First Quarter Financial Results | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |